{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:02:15Z","timestamp":1790359335400,"version":"4.1.0"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Pulmonary arterial hypertension (PAH) is a life-threatening complication of SSc. Although selexipag is approved for SSc-PAH, available data are limited. We evaluated the long-term safety and clinical predictors associated with selexipag therapy in a multicentre Italian cohort of SSc-PAH patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analysed consecutive SSc patients with PAH diagnosed by right heart catheterization and treated with selexipag. Survival, treatment persistence, 1-year mortality risk (COMPERA 2.0) and predictors of clinical outcomes were assessed using appropriate statistical methods.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Fifty-one SSc-PAH patients (94% female, median age 71\u2009years) received selexipag for a median (interquartile range-IQR) duration of 22 (11\u201344)\u2009months. The estimated survival at 3 and 5\u2009years from PAH diagnosis was 88% and 70%, respectively; a lower COMPERA 2.0 was the only significant protective factor. Right ventricular enlargement was associated with higher mortality risk (aOR 0.01, 95% CI 0.01\u20130.27), higher tricuspid annular plane systolic excursion with lower risk (aOR 1.35, 95% CI 1.04\u20131.75). After 12\u2009months of treatment, the COMPERA 2.0 was improved in all patients, but a low risk of death was significantly more frequent in patients starting selexipag within 1\u2009year from PAH onset (38% vs 8%, P\u2009&amp;lt;\u20090.01). Treatment persistence reached 84% at 12\u2009months and baseline combination PAH therapy was associated with lower rates of selexipag discontinuation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Selexipag demonstrated a favourable long-term safety profile in SSc-PAH patients. A preserved right ventricular function represents a key determinant for survival, while early therapeutic combination strategies including selexipag are associated with more favourable COMPERA 2.0 mortality risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keag482","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:31:53Z","timestamp":1788521513000},"source":"Crossref","is-referenced-by-count":0,"title":["Selexipag in SSc-associated pulmonary arterial hypertension: long-term real-world data from a multicentre Italian cohort"],"prefix":"10.1093","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5207-7913","authenticated-orcid":false,"given":"Stefano","family":"Stano","sequence":"first","affiliation":[{"name":"Rheumatology Unit\u2014Department of Precision and Regenerative Medicine, Jonian Area (DiPReMeJ), University of Bari \u2018Aldo Moro\u2019 , Bari,","place":["Italy"]},{"name":"Rheumatology Unit, E.E. Regional General Hospital \u2018F. Miulli\u2019 , Acquaviva delle Fonti (Bari),","place":["Italy"]},{"name":"Department of Medicine and Surgery, LUM \u2018G. Degennaro\u2019 University , Casamassima (Bari),","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5686-0127","authenticated-orcid":false,"given":"Claudia","family":"Iannone","sequence":"additional","affiliation":[{"name":"Scleroderma Clinic, Rheumatology Department, ASST \u2018G. Pini-CTO\u2019, Universit\u00e0 degli Studi di Milano , Milano,","place":["Italy"]},{"name":"Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Scientific Institute, and Vita-Salute San Raffaele University , Milan,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6806-3794","authenticated-orcid":false,"given":"Corrado","family":"Campochiaro","sequence":"additional","affiliation":[{"name":"Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Scientific Institute, and Vita-Salute San Raffaele University , Milan,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Vicenzi","sequence":"additional","affiliation":[{"name":"Department of Cardio-Thoraco-Vascular Diseases, Fondazione IRCCS Ca\u2019 Granda-Ospedale Maggiore Policlinico , Milan,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1860-6866","authenticated-orcid":false,"given":"Maria Grazia","family":"Lazzaroni","sequence":"additional","affiliation":[{"name":"Scleroderma Unit, Rheumatology and Clinical Immunology Unit, ERN ReCONNET Centre, Department of Clinical and Experimental Sciences, ASST Spedali Civili and University of Brescia , Brescia,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1356-8423","authenticated-orcid":false,"given":"Cinzia","family":"Rotondo","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Medical and Surgical Sciences, University of Foggia , Foggia,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Cadar","sequence":"additional","affiliation":[{"name":"Department of Medical and Cardiovascular Sciences, Sapienza University of Rome , Rome,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"De Cata","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Medicine Unit, Casa Sollievo della Sofferenza-IRCCS-San Giovanni Rotondo , Foggia,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Foti","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, A.O.U. \u2018Policlinico-San Marco\u2019 , Catania,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4963-0663","authenticated-orcid":false,"given":"Maria","family":"Iacovantuono","sequence":"additional","affiliation":[{"name":"Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata , Rome,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Zanatta","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University of Padua , Padova,","place":["Italy"]},{"name":"Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova , Padova,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Motta","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Humanitas University, Pieve Emanuele-Milan and IRCCS-Humanitas Research Hospital , Milan,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Grimaldi","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, \u2018Vito Fazzi\u2019 Hospital , Lecce,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Marazia","sequence":"additional","affiliation":[{"name":"Division of Cardiology, \u2018Vito Fazzi\u2019 Hospital , Lecce,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Capparelli","sequence":"additional","affiliation":[{"name":"Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata , Rome,","place":["Italy"]},{"name":"Rheumatology Unit, ASST Ovest Milanese, Legnano Hospital , Milan,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Fortunato","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, LUM \u2018G. Degennaro\u2019 University , Casamassima (Bari),","place":["Italy"]},{"name":"Cardiology Unit, E.E. Regional General Hospital \u2018F. Miulli\u2019 , Acquaviva delle Fonti (Bari),","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Galgano","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, LUM \u2018G. Degennaro\u2019 University , Casamassima (Bari),","place":["Italy"]},{"name":"Cardiology Unit, E.E. Regional General Hospital \u2018F. Miulli\u2019 , Acquaviva delle Fonti (Bari),","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cito","sequence":"additional","affiliation":[{"name":"Rheumatology Unit\u2014Department of Precision and Regenerative Medicine, Jonian Area (DiPReMeJ), University of Bari \u2018Aldo Moro\u2019 , Bari,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Cavazzana","sequence":"additional","affiliation":[{"name":"Scleroderma Unit, Rheumatology and Clinical Immunology Unit, ERN ReCONNET Centre, Department of Clinical and Experimental Sciences, ASST Spedali Civili and University of Brescia , Brescia,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1549-8852","authenticated-orcid":false,"given":"Nicoletta","family":"Del Papa","sequence":"additional","affiliation":[{"name":"Scleroderma Clinic, Rheumatology Department, ASST \u2018G. Pini-CTO\u2019, Universit\u00e0 degli Studi di Milano , Milano,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3487-8551","authenticated-orcid":false,"given":"Roberto","family":"Caporali","sequence":"additional","affiliation":[{"name":"Scleroderma Clinic, Rheumatology Department, ASST \u2018G. Pini-CTO\u2019, Universit\u00e0 degli Studi di Milano , Milano,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Matucci-Cerinic","sequence":"additional","affiliation":[{"name":"Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Scientific Institute, and Vita-Salute San Raffaele University , Milan,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7479-4462","authenticated-orcid":false,"given":"Fabio","family":"Cacciapaglia","sequence":"additional","affiliation":[{"name":"Rheumatology Unit\u2014Department of Precision and Regenerative Medicine, Jonian Area (DiPReMeJ), University of Bari \u2018Aldo Moro\u2019 , Bari,","place":["Italy"]},{"name":"Rheumatology Unit, E.E. Regional General Hospital \u2018F. Miulli\u2019 , Acquaviva delle Fonti (Bari),","place":["Italy"]},{"name":"Department of Medicine and Surgery, LUM \u2018G. Degennaro\u2019 University , Casamassima (Bari),","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0474-5344","authenticated-orcid":false,"given":"Florenzo","family":"Iannone","sequence":"additional","affiliation":[{"name":"Rheumatology Unit\u2014Department of Precision and Regenerative Medicine, Jonian Area (DiPReMeJ), University of Bari \u2018Aldo Moro\u2019 , Bari,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"key":"2026092513461804700_keag482-B1","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41584-024-01217-2","article-title":"An international perspective on the future of systemic sclerosis research","volume":"21","author":"Abraham","year":"2025","journal-title":"Nat Rev Rheumatol"},{"key":"2026092513461804700_keag482-B2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00281-025-01065-6","article-title":"Systemic sclerosis: pathogenic mechanisms and their implications for treatment","volume":"47","author":"Lescoat","year":"2025","journal-title":"Semin Immunopathol"},{"key":"2026092513461804700_keag482-B3","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41584-023-00909-5","article-title":"State-of-the-art evidence in the treatment of systemic sclerosis","volume":"19","author":"Pope","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"2026092513461804700_keag482-B4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00393-023-01401-x","article-title":"Standardized mortality ratios in systemic sclerosis: a meta-analysis assessing overall and sex- and disease subtype-specific differences","volume":"83","author":"Lee","year":"2024","journal-title":"Z Rheumatol"},{"key":"2026092513461804700_keag482-B5","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.semarthrit.2014.05.010","article-title":"Mortality and survival in systemic sclerosis: systematic review and meta-analysis","volume":"44","author":"Rubio-Rivas","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"2026092513461804700_keag482-B6","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1002\/art.38029","article-title":"Survival and prognostic factors in systemic sclerosis-associated pulmonary hypertension: a systematic review and meta-analysis: survival and prognosis in SSc-associated pulmonary hypertension","volume":"65","author":"Lef\u00e8vre","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2026092513461804700_keag482-B7","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3390\/diagnostics11050911","article-title":"Systemic sclerosis-associated pulmonary hypertension: spectrum and impact","volume":"11","author":"Naranjo","year":"2021","journal-title":"Diagnostics"},{"key":"2026092513461804700_keag482-B8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/diseases6020038","article-title":"Pulmonary arterial hypertension: pathophysiology and treatment","volume":"6","author":"Lan","year":"2018","journal-title":"Diseases"},{"key":"2026092513461804700_keag482-B9","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"key":"2026092513461804700_keag482-B10","doi-asserted-by":"publisher","first-page":"1602493","DOI":"10.1183\/13993003.02493-2016","article-title":"Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension","volume":"50","author":"Gaine","year":"2017","journal-title":"Eur Respir J"},{"key":"2026092513461804700_keag482-B11","doi-asserted-by":"publisher","first-page":"NP7","DOI":"10.1177\/2397198320916082","article-title":"Selexipag treatment in patients with systemic sclerosis-associated pulmonary arterial hypertension in clinical practice, a case series","volume":"5","author":"Lemmers","year":"2020","journal-title":"J Scleroderma Relat Disord"},{"key":"2026092513461804700_keag482-B12","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism Collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2026092513461804700_keag482-B13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","article-title":"2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)","volume":"37","author":"Gali\u00e8","year":"2016","journal-title":"Eur Heart J"},{"key":"2026092513461804700_keag482-B14","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"2026092513461804700_keag482-B15","doi-asserted-by":"publisher","first-page":"1759720X251410681","DOI":"10.1177\/1759720X251410681","article-title":"Forced vital capacity as a survival predictor in systemic sclerosis-associated pulmonary hypertension","volume":"18","author":"Iannone","year":"2026","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"2026092513461804700_keag482-B16","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","article-title":"Interstitial lung disease in systemic sclerosis: a simple staging system","volume":"177","author":"Goh","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2026092513461804700_keag482-B17","doi-asserted-by":"publisher","first-page":"2102311","DOI":"10.1183\/13993003.02311-2021","article-title":"COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension","volume":"60","author":"Hoeper","year":"2022","journal-title":"Eur Respir J"},{"key":"2026092513461804700_keag482-B18","doi-asserted-by":"publisher","first-page":"5037","DOI":"10.1007\/s12325-023-02658-z","article-title":"Real-world treatment patterns among patients with connective tissue disorder-related pulmonary arterial hypertension in the United States: a retrospective claims-based analysis","volume":"40","author":"Sargent","year":"2023","journal-title":"Adv Ther"},{"key":"2026092513461804700_keag482-B19","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1002\/art.40862","article-title":"Prevalence, treatment, and outcomes of coexistent pulmonary hypertension and interstitial lung disease in systemic sclerosis","volume":"71","author":"Young","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2026092513461804700_keag482-B20","doi-asserted-by":"publisher","first-page":"e12117","DOI":"10.1002\/pul2.12117","article-title":"Clinical characteristics and outcomes in pulmonary manifestations of systemic sclerosis: contribution from pulmonary hypertension and interstitial lung disease severity","volume":"12","author":"Sangani","year":"2022","journal-title":"Pulm Circ"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keag482\/70984489\/keag482.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/9\/keag482\/70984489\/keag482.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/9\/keag482\/70984489\/keag482.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:46:25Z","timestamp":1790358385000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/doi\/10.1093\/rheumatology\/keag482\/8787420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keag482","relation":{},"ISSN":["1462-0332"],"issn-type":[{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,9,1]]},"article-number":"keag482"}}